Mutation of MeCP2 at T158M Leads to Distinct Molecular and Phenotypic Abnormalities in Male and Female Mice
Cells · 2025
DOI: 10.3390/cells14161286 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Chris-Tiann Roberts und 11 weiteren Autor:innen. Beteiligte Einrichtung: Biochemistry and Medical Genetics, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba, 745 Bannatyne Avenue, Basic…. Hauptthemen laut MEDLINE: Methyl-CpG-Binding Protein 2, Mutation, Rett Syndrome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Sciences and Engineering Research Council of Canada Discovery Grant, Ontario Rett Syndrome Association (ORSA), Children's Hospital Research Institute of Manitoba (CHRIM).
Abstract (Originalsprache)
Methyl CpG-binding protein 2 (MeCP2) is an epigenetic reader of DNA methylation with high abundance in the brain. While genetic mutations occur across different protein domains of MeCP2, the T158M mutation is amongst the most frequent MeCP2 mutations. MeCP2 is encoded by the MECP2/Mecp2 gene located on the X chromosome. In humans, MECP2 mutations cause Rett Syndrome, a debilitating neurodevelopmental disorder in females, with very rare cases presenting in males. Despite the generation of different transgenic mouse lines with MeCP2 mutations, the sex-dependent phenotypic and molecular impact of common MeCP2 mutations in mouse models of disease remains largely unexplored. Here, we focus on the MeCP2 T158M mutation using Mecp2tm4.1Bird/J transgenic mice (referred to as Mecp2T158M), and report that Mecp2T158M mutant mice display sex-specific molecular, behavioural, and phenotypic characteristics when compared to wild-type controls. Our data indicates sex- and brain-region-dependent impacts on the expression of MeCP2, synaptic proteins, cytoskeletal markers, and autophagy factors. Our findings demonstrate that the phenotypic and molecular characteristics of this mouse model may relate to the clinical manifestation in human patients with Rett Syndrome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biochemistry and Medical Genetics, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba, 745 Bannatyne Avenue, Basic Medical Sciences Bldg. Room 627, Winnipeg, MB R3E 0J9, Canada.
ORCID-Profile: Chris-Tiann Roberts, Ashraf Kadar Shahib, Mojgan Rastegar
Förderung
- Natural Sciences and Engineering Research Council of Canada Discovery Grant
- Ontario Rett Syndrome Association (ORSA)
- Children's Hospital Research Institute of Manitoba (CHRIM)
- Canadian Institutes of Health Research (CIHR) Project Grant
- Ontario Rett Syndrome Association (ORSA) Hope Fund
- Children’s Hospital Research Institute of Manitoba (CHRIM) Operating Grant
- University of Manitoba Collaborative Research Grant (UCRP)
Zitieren
APA
Roberts, C. T., Kadar Shahib, A., Arezoumand, K. S., Akhtar, G. B., Nejati-Koshki, K., Jarmasz, J. S., Ziaee, S. M., Buist, M., Raabe, N., Rezaeian Mehrabadi, A., Olson, C. O., & Rastegar, M. (2025). Mutation of MeCP2 at T158M Leads to Distinct Molecular and Phenotypic Abnormalities in Male and Female Mice. Cells. https://doi.org/10.3390/cells14161286
Vancouver
Roberts CT, Kadar Shahib A, Arezoumand KS, Akhtar GB, Nejati-Koshki K, Jarmasz JS, et al. Mutation of MeCP2 at T158M Leads to Distinct Molecular and Phenotypic Abnormalities in Male and Female Mice. Cells. 2025. doi:10.3390/cells14161286
BibTeX
@article{Roberts2025,
author = {Roberts, Chris-Tiann and Kadar Shahib, Ashraf and Arezoumand, Khatereh Saei and Akhtar, Ghanan Bin and Nejati-Koshki, Kazem and Jarmasz, Jessica S and Ziaee, Seyyed Mohyeddin and Buist, Marjorie and Raabe, Nicole and Rezaeian Mehrabadi, Abbas and Olson, Carl O and Rastegar, Mojgan},
title = {Mutation of MeCP2 at T158M Leads to Distinct Molecular and Phenotypic Abnormalities in Male and Female Mice},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14161286}
}
EUVIMED